MedPath

广东和平药业有限公司

Ownership
-
Established
2002-09-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

68

NMPA:68

Drug Approvals

珍珠灵芝片

Approval Number
国药准字Z20053282
Approval Date
Sep 15, 2020
NMPA

银翘解毒片

Approval Number
国药准字Z44021245
Approval Date
Dec 31, 2019
NMPA

昆明山海棠片

Approval Number
国药准字Z44021240
Approval Date
Dec 31, 2019
NMPA

穿心莲片

Approval Number
国药准字Z44022371
Approval Date
Dec 31, 2019
NMPA

参苓白术胶囊

Approval Number
国药准字Z44021202
Approval Date
Dec 10, 2019
NMPA

Ethambutol Hydrochloride Tablets

Product Name
盐酸乙胺丁醇片
Approval Number
国药准字H44021932
Approval Date
Dec 10, 2019
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H44021923
Approval Date
Dec 10, 2019
NMPA

银翘解毒颗粒

Approval Number
国药准字Z44021244
Approval Date
Dec 10, 2019
NMPA

Bromhexine Hydrochloride Tablets

Product Name
盐酸溴己新片
Approval Number
国药准字H44021934
Approval Date
Dec 10, 2019
NMPA

Promethazine Hydrochloride Tablets

Product Name
盐酸异丙嗪片
Approval Number
国药准字H44021933
Approval Date
Dec 10, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.